Tandem unveils free software update for predictive glucose tracking and insulin delivery | Digital Science

Diabetes Care launched a new feature designed to help reduce the frequency and duration of low- events by pausing . The technology is available as a for its t:slim X2 insulin pumps using the Dexcom G6 continuous glucose monitoring system.

Pumps preloaded with the new technology, titled Basal-IQ, are expected to begin shipping by the end of the month, the San Diego, California-based company said. The software update will require a new prescription and completion of a 45-minute online training module, both coordinated through an online portal.

The Basal-IQ algorithms are designed to predict trends in glucose levels up to 30 minutes ahead, suspending insulin when low levels are anticipated, and automatically resuming when glucose numbers begin to rise.

Your Daily Newsletter — Free

Enjoying this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. To read on the go, sign up today to get biotech news and updates delivered right to your inbox!

“This launch marks the achievement of our goal to offer people with diabetes a simple-to-use automated insulin delivery feature that can reduce time spent low without adding significant burden to the pump therapy experience,” Tandem’s president and CEO, Kim Blickenstaff, said in a statement.

In a clinical study, Basal-IQ demonstrated a 31% reduction in time spent below 70 mg/dL, with no rebound hyperglycemia compared to a CGM-enabled insulin pump without the feature, Tandem said.

RELATED: FDA approves Tandem’s insulin pump with Dexcom CGM integration

Tandem first received FDA approval in August of last year for its touchscreen insulin pump, using Dexcom’s G5 CGM platform, which allowed patients to make treatment decisions without pricking their finger. At the time, Tandem rolled out a remote software update to users to allow them to view insulin delivery activity alongside CGM data from the implanted Dexcom sensor on the t:slim X2’s screen.

You might also like More from author